Sunvozertinib
Sunvozertinib (DZD9008) is a selective small molecule inhibitor targeting EGFR and Her2 mutations, including various exon 20 insertions and the L858R/T790M double mutation. It has demonstrated potent activity in preclinical in vitro and in vivo models of non-small cell lung cancer (NSCLC), supporting its investigation for targeted cancer therapy.
Product Specifications
CAS Number
2370013-12-8
Product Name Alternative
EGFR, DZD 9008, DZD9008, DZD-9008, BTK, Sunvozertinib
Field of Research
Cardiovascular Research, Signal Transduction
Purity
98.11% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (8.56 mM) ; DMSO:247.5 mg/mL (423.74 mM)
Smiles
COc1cc (N2CC[C@H] (C2) N (C) C) c (NC (=O) C=C) cc1Nc1nccc (Nc2cc (Cl) c (F) cc2C (C) (C) O) n1
Molecular Formula
C29H35ClFN7O3
Molecular Weight
584.08
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Cy3-Linked Polyclonal Antibody to Hexokinase 1 (HK1)
Cy3-Linked Polyclonal Antibody to Hexokinase 1 (HK1)
Cy3-Linked Polyclonal Antibody to Hexokinase 1 (HK1)
Cy3-Linked Polyclonal Antibody to Hexokinase 1 (HK1)